( OTC-QB:BRRY,OTC-QB:DMPI )

News from DelMar Pharmaceuticals A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Oct 06, 2014, 11:47 ET DelMar Pharmaceuticals Announces Presentations at Upcoming Scientific Meetings

DelMar Pharmaceuticals, Inc., (OTCQB: DMPI), a clinical-stage oncology company, today announced that the company has been invited to present new...


Sep 04, 2014, 08:00 ET DelMar Pharmaceuticals to Present at the SeeThruEquity Fall Microcap Investor Conference

 DelMar Pharmaceuticals, Inc., (OTCQB: DMPI), a clinical-stage oncology company, will be featured as a presenting company at the SeeThruEquity...


Nov 14, 2013, 08:00 ET DelMar Pharmaceuticals to Present Interim Clinical Data for VAL-083 in Glioblastoma at Society of Neuro-Oncology

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma") today announced that the Company will present interim clinical...


Nov 11, 2013, 08:00 ET DelMar Pharmaceuticals Gives Quarterly Shareholder Update

Dear Shareholders and Friends of DelMar Pharmaceuticals: I am pleased to provide you with an update as of the quarter ended September 30, 2013 and...


Oct 15, 2013, 08:00 ET DelMar Pharmaceuticals to Present at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Annual Meeting

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" or "DelMar Pharma") today announced that the company would present an abstract entitled...


Oct 09, 2013, 08:00 ET DelMar Pharma talks to Life Sciences IP Review (LSIPR) about creating new patents for shelved drugs to streamline path to patients

 The president and CEO of DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar Pharma" or "DelMar") Jeffrey Bacha spoke to Life Science IP...


Sep 19, 2013, 08:00 ET DelMar Pharma reviews glioblastoma clinical trials and new therapeutic development on CEOLIVE.TV

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar Pharma" or "DelMar") today announced a discussion on CEOLIVE.TV by Jeffrey Bacha,...


Sep 09, 2013, 08:00 ET DelMar Pharmaceuticals and Guangxi Wuzhou Pharmaceuticals Establish Clinical Advisory Board in China

DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") and Guangxi Wuzhou Pharmaceutical (Group) Co. Ltd., a subsidiary of Guagxi Wuzhou Zhongeng...


Sep 03, 2013, 08:00 ET DelMar Pharmaceuticals To Present At The 15th Annual Rodman & Renshaw Global Investment Conference

 DelMar Pharmaceuticals, Inc., (OTCQB: DMPI), developer of advanced cancer therapeutics, will be featured as a presenting company at the 15th...


May 28, 2013, 08:00 ET DelMar Pharmaceuticals to Present Clinical Trials Data for VAL-083 Brain Cancer Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") today announced that the company would present an abstract entitled "Phase I/II Study of...


Mar 11, 2013, 08:00 ET DelMar Pharmaceuticals to Present at the 25th Annual ROTH Capital Partners Growth Stock Conference

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar"), a clinical and commercial stage drug development company with a focus on the treatment...


Jan 25, 2013, 12:50 ET DelMar Pharmaceuticals Announces Acquisition and $5.4 Million Private Placement to Advance Novel Cancer Therapies

 DelMar Pharmaceuticals, Inc. (OTCQB: BRRY) ("DelMar") today announced the successful acquisition (the "Acquisition"), through a share exchange...